DEARhealth is a Dutch-American healthcare spin-out from the University of Los Angeles, California. The company develops artificial intelligence-powered, personalized care pathways for chronic care.

DEARhealth offers Value-based Health Care solutions for medical providers and health insurers, which significantly improve the health outcomes and experience of chronically ill patients while dramatically reducing costs.

DEARhealth was founded in 2013 by Daniel Hommes and Eric Esrailian. The company is headquartered in Los Angeles, California, with an office in Amsterdam, Netherlands.


DEARhealth supports Value Based Health Care and aims to get the best outcomes for patients and providers, optimizing a value quotient (vQ), defined as patient value/provider costs. Treatment areas include inflammatory bowel disease, pain management, liver diseases, ovarian cancer, chronic kidney diseases, low back pain and epilepsy.


DEARhealth's proprietary platform aims to improve patient health outcomes and experiences while reducing healthcare costs. It works for patients, the healthcare ecosystem and the pharmaceutical- and medical devices industries to develop help drive innovative health solutions.


DEARhealth is backed by Philips Health Technology Ventures, Vesalius Bio Capital lll and Health Innovations. The company raised $6.8M in a Series A financing on Jul 17, 2019. 



  • Year founded: 2013
  • Funding Info: $6.8M over 2 Rounds (Latest Funding Type: Series A)
  • Yearly Revenue: NA
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: Los Angeles
  • State: California
  • Country: United States
Related businesses